Current studies into retatruptide peptide demonstrate promising potential for managing obesity and type 2 diabetes mellitus. The peptide, a dual stimulator of GLP-1 and GIP, seems to provide improved weight reduction and blood sugar regulation versus existing therapies. Additional clinical trials are necessary to completely determine its well-be… Read More